A team of researchers has developed a sugar-based stent that provides structural support during challenging microvascular suturing surgeries. The stent, which is 3D printed to match the diameters of specific arteries, fits inside the adjacent ends of a blood vessel while the stitching process takes place—and then quickly dissolves after blood flow resumes.

Although the 2018 U.S. stroke guidelines recommended extending the window for endovascular thrombectomy (EVT) to 24 hours in select stroke patients, a new meta-analysis in JAMA Neurology serves as a reminder that prompt treatment remains crucial for achieving successful reperfusion.

Aspirin offers modest protection against cardiovascular events in primary prevention, but that benefit is at least partially offset by an increase in major bleeding events, according to a meta-analysis published Jan. 22 in JAMA.

Medtronic hopes newly presented five-year survival data put to rest any concerns about the long-term safety of the company’s IN.PACT Admiral drug-coated balloon (DCB).

The FDA is looking into the signal of increased late mortality associated with paclitaxel-coated balloons and stents that was observed in a recent meta-analysis of patients treated for femoropopliteal artery disease.

Older age, smoking and a higher body mass index (BMI) were consistently associated with a heightened risk of venous thromboembolism (VTE) in an analysis of 1.1 million individuals published in JAMA Cardiology.

Long-term sufferers of post-traumatic stress disorder (PTSD) are at a higher risk for circulatory and metabolic diseases, especially if they’re men, according to research out of Siena, Italy.

Executives from Medtronic and Boston Scientific stood behind their companies’ paclitaxel-coated medical devices after a meta-analysis published in the Journal of the American Heart Association in December linked balloons and stents covered with the material to a significantly increased risk of death at two and five years of follow-up.